Alan G. Levin - Jul 1, 2021 Form 4 Insider Report for Diffusion Pharmaceuticals Inc. (DFFN)

Role
Director
Signature
/s/ William R. Elder, as attorney-in-fact for the Reporting Person
Stock symbol
DFFN
Transactions as of
Jul 1, 2021
Transactions value $
$0
Form type
4
Date filed
7/6/2021, 09:42 PM
Previous filing
May 27, 2021
Next filing
Sep 2, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DFFN Stock Option (Right to Buy) Award $0 +83.3K $0.00 83.3K Jul 1, 2021 Common Stock 83.3K $0.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the options will vest in 12 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a 12-month period beginning July 1, 2021.